top of page

Free Biopharma Daily Stock Updates - 09/02/21

$XBI $136.53 +1.07%

 

Covid Updates

$SRNE +0.1% Sorrento Announces Enrollment of First Subject in Brazil Phase 2 Study of COVI-MSC for Treatment of COVID-19 Associated Acute Respiratory Distress in ICU Patients. source


$CLSN +2.9% Celsion Reports T-cell and B-cell Response from In Vivo Studies with its PLACCINE DNA Vaccine Platform. source



Pipeline Updates

$ATOS +1.1% Atossa Therapeutics Receives Approval from the Swedish Ethics Review Authority to Initiate a Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast Density in Sweden. source


$HRMY +2.1% Harmony Biosciences Announces Inclusion Of WAKIX® (pitolisant) In American Academy Of Sleep Medicine's Updated Clinical Practice Guideline. source


$CNTB -4.9% Connect Biopharma Announces First Patient Dosed in China Pivotal Trial Evaluating CBP-201 in Adults with Moderate-to-Severe Atopic Dermatitis. source


$ADMP +2.7% Adamis Pharmaceuticals Doses First Patients in Phase 2/3 Clinical Trial for Tempol in the Treatment of COVID-19. source


$FLXN +7.6% Flexion Therapeutics Announces Inclusion of ZILRETTA® in American Academy of Orthopaedic Surgeons (AAOS) Clinical Practice Guidelines for the Management of Osteoarthritis of the Knee. source


$PSTV +7.9% Plus Therapeutics Announces Commercial Manufacturing Supply Agreement for Its Lead Investigational Drug.


$DTIL +3.4% Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment. source


$TLSA +21.1% Tiziana Life Science - License Agreement to Evaluate Foralumab with CAR T. source


$VRNA +3.4% Verona Pharma Presents Pharmacokinetic Data with Ensifentrine at the European Respiratory Society International Congress 2021. source


$ASMB -16.2% Assembly Bio Announces Decision to Discontinue Clinical Development of ABI-H2158. source


$HTBX -10.1% Heat Biologics to Provide Corporate Update; conference call on 9/2/21 at 11AM ET. source


$IPHA +17.8% Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual Congress. source


 

Posted by FS

0 comments
bottom of page